GlassScriptPhysician profile
Antonio B Roa
NPI 1932137957
$634.53
in general payments reported to CMS, 2019-2025
14 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.40 · 2020: $103 · 2021: $203 · 2022: $64.12 · 2024: $70.76 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $173.91 | 2020-2022 | |
| Amgen INC. | $105.79 | 2019-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $57.77 | 2021-2025 | |
| Esperion Therapeutics, INC. | $48.11 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $41.22 | 2021 | |
| Novartis Pharmaceuticals Corporation | $40.60 | 2019 | |
| Exact Sciences Corporation | $28.72 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $26.90 | 2024 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $25.82 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.33 | 2022 | |
| Corcept Therapeutics | $18.96 | 2025 | Korlym |
| Antares Pharma, INC. | $15.68 | 2022 | |
| Novo Nordisk INC | $15.17 | 2019 | |
| Horizon Therapeutics Plc | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Roa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.